Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
The Biden administration made direct payments to nearly all major corporate media outlets to deploy a $1 billion taxpayer-funded outreach campaign designed to push only positive coverage about COVID-19 vaccines and to censor any negative coverage, according to documents obtained by The Blaze.
Cardiologist, professor and frontline doctor Peter McCullough asserts that early COVID-19 testing data indicates the genetic materials in the vaccine could be incorporated into the human genome.